Stock futures rise after upbeat tech earnings: Live updates

Stock futures rise after upbeat tech earnings: Live updates


Traders work on the floor of the New York Stock Exchange in New York on Oct. 30, 2025.

Angela Weiss | AFP | Getty Images

Stock futures rose Thursday night as investors pored over a couple of key earnings reports from Big Tech companies.

Futures tied to the Dow Jones Industrial Average added 17 points, or 0.05%. S&P futures gained 0.5%, while Nasdaq 100 futures added 1%.

Apple and Amazon posted quarterly results after market close Thursday, capping off a big week for tech results. Amazon shares rallied more than 13% after the e-commerce giant said its cloud computing unit’s revenue increased 20% in the third quarter, exceeding Wall Street’s estimates. Apple, meanwhile, rose about 3% on the back of its strong fiscal fourth-quarter earnings and forecast for the iPhone maker’s December quarter.

Streaming leader Netflix added more than 3% after the company announced a 10-for-1 stock split.

“We’re in this period where the government is shut down … so we really have to look at these earnings and see how are companies faring, how are their consumers faring,” Courtney Garcia, senior wealth advisor at Payne Capital Management said Thursday on CNBC’s “Closing Bell Overtime.” “The fact that we’re continuing to see this all come out positive, I think this is a generally good sign for the economy moving forward.”

U.S. stocks are coming off of a lackluster session as each of the benchmark indexes closed Thursday in the red. The Dow Jones Industrial Average fell nearly 110 points, or about 0.2%. The S&P 500 and Nasdaq Composite lost 0.99% and 1.58%, respectively, dragged lower by losses in big-name tech stocks Meta, Microsoft and Nvidia amid concerns about increasing AI spending. Meta recorded its biggest one-day loss in three years.

President Donald Trump and President Xi Jinping on Thursday reached a one-year trade truce after their meeting in South Korea, soothing some investor concerns about the possibility of an all-out trade war between both nations.

Trump agreed to cut tariffs on China tied to fentanyl by 10% effective immediately, reducing overall levies on Chinese goods to around 47%, while Beijing agreed to a one-year pause on the export controls for rare earths it announced earlier this month. Other areas of dispute, such as export controls on sales of Nvidia’s advanced AI chips and the divestiture of U.S. TikTok operations, were unresolved, however.

U.S. stock indexes are on track to close out a winning week and month. The S&P 500 has gained 0.45% so far this week, while the tech-heavy Nasdaq and Dow are up roughly 1.6% and 0.7%, respectively, week to date.

October — which has experienced some of the largest one-day losses in stock market history — has seen the S&P 500 climb 2% over the month. The Nasdaq has jumped nearly 4.1% and the 30-stock Dow is up 2.4% month to date. The Dow is on pace for its sixth positive month in a row for the first time since 2018.



Source

Trump says India will stop buying Russian oil. Shadow fleet vessels are still unloading sanctioned crude at its ports
World

Trump says India will stop buying Russian oil. Shadow fleet vessels are still unloading sanctioned crude at its ports

The oil tanker “Grinch” (R), suspected of belonging to the Russian’s shadow fleet, is seen outside the coast of Martigues near the port of Marseille-Fos on January 25, 2026, as it’s surveilled by the French Navy. Thibaud Moritz | Afp | Getty Images President Donald Trump announced a U.S. trade deal with India on Monday […]

Read More
Ray Dalio warns the world is ‘on the brink’ of a capital war
World

Ray Dalio warns the world is ‘on the brink’ of a capital war

Ray Dalio, founder of Bridgewater Assoc., speaking on CNBC’s Squawk Box at the World Economic Forum in Davos, Switzerland on Jan. 20th, 2026. Oscar Molina | CNBC Legendary investor Ray Dalio warned on Tuesday that the world is “on the brink” of a capital war, amid simmering geopolitical tensions and volatile capital markets. Speaking to […]

Read More
Merck tops quarterly estimates, posts modest 2026 guidance as generic competition looms
World

Merck tops quarterly estimates, posts modest 2026 guidance as generic competition looms

Merck on Tuesday reported fourth-quarter earnings and revenue that topped estimates on strong demand for its cancer immunotherapy Keytruda and some newer products.  But the company posted a modest 2026 outlook that fell short of Wall Street’s expectations as it prepares for a few drugs to lose patent protection later this year and face generic […]

Read More